|
Cp-4200
Looks like that company is going at attached the fatty acid not only to Vizada (azacytidine becomes CP-4200), but also to Gemzar (gemcitabine becomes CP-4126). If their research is true, having the fatty acid attached to these known cancer drugs will improve their cellular uptake since they're less dependent on the nucleoside transporters, which supposedly improves their efficacy against various cancers. Hooray!
|